Cymabay Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CYMABAY, and what generic alternatives to CYMABAY drugs are available?
CYMABAY has one approved drug.
There are six US patents protecting CYMABAY drugs.
There are one hundred and eight patent family members on CYMABAY drugs in forty-two countries.
Summary for Cymabay
| International Patents: | 108 |
| US Patents: | 6 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Cymabay
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cymabay | LIVDELZI | seladelpar lysine | CAPSULE;ORAL | 217899-001 | Aug 14, 2024 | RX | Yes | Yes | 11,596,614 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Cymabay | LIVDELZI | seladelpar lysine | CAPSULE;ORAL | 217899-001 | Aug 14, 2024 | RX | Yes | Yes | 7,709,682 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Cymabay | LIVDELZI | seladelpar lysine | CAPSULE;ORAL | 217899-001 | Aug 14, 2024 | RX | Yes | Yes | 9,486,428 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Cymabay | LIVDELZI | seladelpar lysine | CAPSULE;ORAL | 217899-001 | Aug 14, 2024 | RX | Yes | Yes | 10,272,058 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Cymabay | LIVDELZI | seladelpar lysine | CAPSULE;ORAL | 217899-001 | Aug 14, 2024 | RX | Yes | Yes | 11,406,611 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Cymabay | LIVDELZI | seladelpar lysine | CAPSULE;ORAL | 217899-001 | Aug 14, 2024 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Cymabay Drugs
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
